HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
about
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief OverviewPotential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairmentMitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infectionSoluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected womenUp-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorderA genetic and functional relationship between T cells and cellular proliferation in the adult hippocampusNuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes.Evidence of the innate antiviral and neuroprotective properties of progranulin.Glutamate metabolism and HIV-associated neurocognitive disorders.HIV associated dementia and HIV encephalitis II: Genes on chromosome 22 expressed in individually microdissected Globus pallidus neurons (Preliminary analysis).The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disordersValproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individualsChemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure.Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic miceSIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS.Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysisRodent models for HIV-associated neurocognitive disorders.The cerebrospinal fluid proteome in HIV infection: change associated with disease severityOf mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIVTarget of HIV-1 Envelope Glycoprotein gp120-Induced Hippocampal Neuron Damage: Role of Voltage-Gated K(+) Channel Kv2.1.Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat.Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60.Envelope gene evolution and HIV-1 neuropathogenesis.Current understanding of HIV-associated neurocognitive disorders pathogenesis.A plasma microRNA signature of acute lentiviral infection: biomarkers of central nervous system disease.MicroRNA-142 reduces monoamine oxidase A expression and activity in neuronal cells by downregulating SIRT1.HIV reservoirs and the possibility of a cure for HIV infection.Role of p53 in neurodegenerative diseases.HIV-associated neurological disorders: a guide to pharmacotherapy.Animal models for depression associated with HIV-1 infection.Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.Immune activation in the central nervous system throughout the course of HIV infection.High prevalence of suspected HIV-associated dementia in adult Malawian HIV patients.Δ9-Tetrahydrocannabinol Suppresses Secretion of IFNα by Plasmacytoid Dendritic Cells From Healthy and HIV-Infected Individuals.Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users.Prevalence and Correlates of Probable HIV-Associated Dementia in HIV Outpatients in Ho Chi Minh City, Vietnam.
P2860
Q26770401-EBE097F5-520D-4F43-AEA2-023C6A02AAEAQ27011876-14ED61F2-17F0-43C1-8874-5810F38F319DQ28396045-72F57DC1-BC63-40DC-8535-10EABB9C9ED4Q28729739-E77AA380-FDEE-47D8-94A9-E33EC771CB39Q30504584-F14B088D-E8AB-4A71-A4E0-E272B02955A6Q30993422-374C70D1-FDAE-40FD-8947-18D3A7B6833BQ33649838-BAF51E5C-3305-4EFA-A537-54CB6B71B553Q33684254-6FCA1E03-4792-4DA3-8985-9E7DCC44940CQ33690042-5D65E8D7-9D14-4DAF-857B-ECC5A3002578Q33903612-8A79A645-B8E0-48F3-B576-197AC7EC37AAQ33954259-A298E03A-AAED-4920-8E21-4315E170D491Q34248380-3ABAA9A4-033C-4BB8-A023-A8FF18956AD0Q34517239-77856B06-5962-4CCD-8906-297F0C084B6BQ34652709-27F6EAD8-C850-4474-95EF-A0C56584054BQ35006443-AEF087CE-6E23-472A-BC81-E55F242FFDD3Q35125996-645003AB-E6CF-42BF-9A7B-85E79F40CDEDQ35559749-33DD0825-606D-4A84-8E36-86A1336636C3Q35669020-70D3E026-74B9-4666-A597-CF5D7F8B4FACQ35790117-21D4587E-522D-46F8-9080-2F5B7CFBADD9Q35803957-31C6B2C6-B161-4FB0-B34E-D5E7407CC72FQ35965332-20009F49-FAD5-45E1-9CC7-0A992EB5BCD8Q35984276-986CC9A9-A578-42E6-912A-C35ADB4861C4Q36200256-4ECC382D-5C9E-47DF-AD19-9BFE1DD11C8EQ36274448-BE12E268-BF7F-41A1-B344-4372242B82F0Q36338186-548055BE-FD04-469C-AA73-241399C548A3Q36520504-0C117386-5D03-4D92-8616-68BA9E8698B3Q36847475-4D60AA1E-E224-4AAC-AF44-F7E60C332EE7Q36932005-DAA65D5E-2BBD-44B9-84FB-F4F3D83D0010Q36989920-43470A88-865C-438F-A5F1-7C0E0EAA2F1CQ37296879-F1A7E198-9A3E-40FA-A58F-953DC48DB32EQ37935109-E391D999-E759-43B7-B57D-8687DAFE774DQ37951338-AD75FEE0-2AA4-4934-884E-0E881255317FQ37971469-63992D63-1ACF-4B20-AD19-748258E530F9Q38171363-CE3E816F-8FCB-4CA2-A203-04D74DC10976Q38247035-809BD32D-E2E2-4BCB-87FD-E9287602BD84Q38694693-83E42E2A-E704-4339-B130-95A6C0BD3CEFQ39934783-D03ECBF8-5410-4EC2-850B-17ED2713E1D5Q40129268-CDC8EFBD-E13A-434D-80BC-911101C72D30Q42243533-F578F66A-AD47-4B3B-9FFE-D746AFB7DE8CQ47404583-82B7C668-7E12-428F-9CE4-371EDF3D7226
P2860
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
@en
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
@nl
type
label
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
@en
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
@nl
prefLabel
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
@en
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
@nl
P2860
P1476
HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
@en
P2093
Marcus Kaul
P2860
P304
P356
10.1097/WCO.0B013E328329CF3C
P577
2009-06-01T00:00:00Z